Clinical Trials on Retinitis Pigmentosa 15 in Austria

Total 122 results

Kiora Pharmaceuticals, Inc.

Recruiting

A Phase I/II Dose-escalating Study of the Safety, Tolerability and Efficacy of KIO-301 Administered Intravitreally to Patients With Retinitis Pigmentosa and Choroideremia (ABACUS) (ABACUS)

Retinitis Pigmentosa | Choroideremia

Australia
Mobius Medical Pty Ltd.
University of Melbourne; Australian National University; Centre for Eye Research... and other collaborators

Completed

Study of a Suprachoroidal Retinal Prosthesis

Retinitis Pigmentosa | Choroideremia

Australia
Center for Eye Research Australia
Australian National University; Commonwealth Scientific and Industrial Research... and other collaborators

Enrolling by invitation

Longitudinal Study of a Bionic Eye

Retinitis Pigmentosa | Choroideremia

Australia
Center for Eye Research Australia

Completed

Pilot Study of a Suprachoroidal Retinal Prosthesis

Retinitis Pigmentosa | Choroideremia

Australia
Pixium Vision SA

Completed

Restoring Vision With the Intelligent Retinal Implant System (IRIS V1)in Patients With Retinal Dystrophy (IRIS-1)

Retinitis Pigmentosa | Choroideremia | Cone Rod Dystrophy

Austria, France, Germany
PYC Therapeutics

Recruiting

Natural History of PRPF31 Mutation-Associated Retinal Dystrophy

Retinitis Pigmentosa | Eye Diseases, Hereditary | Retinal Dystrophies | Retinal Dystrophy Rod | Retinal Dystrophy Rod Progressive

United States, Australia
Pixium Vision SA

Completed

Compensation for Blindness With the Intelligent Retinal Implant System (IRIS V2) in Patients With Retinal Dystrophy (IRIS 2)

Retinitis Pigmentosa | Choroideremia | Cone Rod Dystrophy

Austria, Spain, United Kingdom, France, Germany
Johns Hopkins University
Mayo Clinic; Medical University of Graz; Radboud University Medical Center; University... and other collaborators

Recruiting

Oral N-acetylcysteine for Retinitis Pigmentosa (NAC Attack)

Retinitis Pigmentosa

United States, Austria, Mexico, Netherlands, United Kingdom, Germany, Canada, Switzerland
Jaeb Center for Health Research
Foundation Fighting Blindness

Recruiting

Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants (Uni-Rare)

Retinitis Pigmentosa | Inherited Retinal Degeneration

United States, United Kingdom, France, Finland, Israel, Netherlands, Switzerland, Australia, Canada, Brazil, Mexico
Ono Pharmaceutical Co. Ltd

Completed

Phase II Study Evaluating ONO-4053 and Cetirizine in Subjects With Seasonal Allergic Rhinitis

Seasonal Allergic Rhinitis

Austria
Medical University of Vienna
Allergy Centre Vienna West

Completed

Effect of Intranasal Corticosteroids on Systemic Allergen Specific IgE

Seasonal Allergic Rhinitis

Austria
University Hospital of Cologne
Bencard Allergie GmbH

Completed

Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe

Perennial Allergic Rhinitis

Austria
GlaxoSmithKline

Completed

Trial With Rhinitic Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber

Rhinitis, Allergic, Seasonal | Seasonal Allergic Rhinitis

Austria
GlaxoSmithKline

Completed

Trial With Allergic Rhinitis Patients Taking GSK256066 Versus Placebo In A Pollen Challenge Chamber

Rhinitis, Allergic, Seasonal | Seasonal Allergic Rhinitis

Austria
Respivert Ltd

Completed

Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic Rhinitis

Seasonal Allergic Rhinitis

Austria
Stallergenes Greer

Completed

Efficacy and Safety of Sublingual Tablets of Grass Pollen Allergen Extract

Seasonal Allergic Rhinitis

Austria
Faes Farma, S.A.

Completed

A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of Bilastine in the Vienna Challenge Chamber

Seasonal Allergic Rhinitis

Austria
GlaxoSmithKline

Completed

A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge Chamber

Allergic Rhinitis | Rhinitis, Allergic, Perennial

Austria
GlaxoSmithKline

Completed

A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis

Allergic Rhinitis | Rhinitis, Allergic, Seasonal

Austria
Medical University of Vienna
University of Vienna

Completed

Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration

Acute Renal Failure | Cytomegalovirus Retinitis

Austria
Medical University of Vienna
AstraZeneca

Completed

Kinetics of Nasal Cytokine Responses to Mechanical Stimulation

Allergic Rhinitis Due to Grass Pollen | Allergic Asthma

Austria
Research Consult GmbH

Completed

Investigate Two Trial Models; Vienna Challenge Chamber (in and Out of Season) and Park Study (in Season) Using a Drug for Seasonal Allergic Rhinitis

Allergic Rhinitis | Rhinitis, Allergic, Seasonal

Austria
GlaxoSmithKline

Completed

A Proof of Concept Study to Assess Effect of Fluticasone Furoate (FF)/Levocabastine Fixed Dose Combination (FDC) Compared With Levocabastine and FF Alone in Subjects With Allergic Rhinitis (AR)

Rhinitis, Allergic, Perennial and Seasonal

Austria
Oxagen Ltd

Completed

A Study Of The Effects Of OC000459 In Subjects Known To Suffer From Grass Pollen Induced Allergic Rhinitis

Allergic Rhinitis

Austria
Gilead Sciences

Completed

Study to Investigate Effects of CAL-263 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber

Allergic Rhinitis

Austria
Marinomed Biotech AG

Completed

Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray

Allergic Rhinitis | Allergic Conjunctivitis | Hayfever

Austria
Gilead Sciences

Completed

Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber

Allergic Rhinitis

Austria
GlaxoSmithKline

Completed

A Phase II Study Evaluating Intranasal GSK256066 and Fluticasone Propionate in Subjects With Seasonal Allergic Rhinitis (SAR)

Rhinitis, Allergic, Seasonal

Austria
Biomay AG

Completed

Safety and Dose Finding Trial of BM32 in Subjects Suffering From Grass Pollen Allergy

Grass Pollen Allergy

Austria
GlaxoSmithKline

Completed

Intranasal SB-705498 in Allergic Rhinitis (AR) Patients

Rhinitis

Austria
Medical University of Vienna

Completed

Changes in Adaptive Immune Responses and Effector Cell Responses Upon Nasal Allergen Exposure - a Pilot Study

Allergic Rhinitis | Allergic Inflammation

Austria
Medical University of Vienna
Austrian Science Fund (FWF)

Completed

Sublingual Immunotherapy of Birch Pollen Associated Apple Allergy

Birch Pollen Allergy | Birch Pollen Related Apple Allergy

Austria
Medical University of Graz
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Active, not recruiting

Integrative Omics Approach to Allergic Rhinitis (IntegOmics)

Allergic Rhinitis

Austria
Oxagen Ltd

Completed

OC000459 Dose Finding Study in Hay Fever Sufferers.

Allergic Rhinitis

Austria
Nacuity Pharmaceuticals, Inc.
Foundation Fighting Blindness

Active, not recruiting

Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome (SLO RP)

Usher Syndromes

Australia
Marinomed Biotech AG

Completed

Demonstration of a Decongestant Effect of "Coldamaris Akut" Compared to Saline Nasal Spray.

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Austria
Marinomed Biotech AG

Completed

Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Austria
Medical University of Vienna

Completed

Iron and Pollen Allergy in Women

Healthy | Allergy Pollen

Austria
Marinomed Biotech AG

Completed

Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis

Allergic Rhinitis | Allergic Conjunctivitis

Austria
Medical University of Vienna

Completed

Characterisation of the Nasal Microbiome in Patients With N-ERD (MicroNERD)

Chronic Rhinitis | Aspirin Exacerbated Respiratory Disease

Austria
Bayside Health

Completed

Immunological Mechanisms of Oralair® in Patients With Seasonal Allergic Rhinitis

Allergic Rhinitis

Australia
Rhythm Pharmaceuticals, Inc.

Completed

Setmelanotide in Pediatric Patients With Rare Genetic Diseases of Obesity

Bardet-Biedl Syndrome | POMC Deficiency Obesity | PCSK1 Deficiency Obesity | LEPR Deficiency Obesity

United States, Australia, Spain, United Kingdom
MacroArray Diagnostics GmbH

Completed

Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX²) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority Allergens (MADMAX)

Cat Allergy | Grass Pollen Allergy | Birch Pollen Allergy | House Dust Mite Allergy | Bee Venom Allergy | Vespid Venom Allergy

Austria
Egalet Ltd

Completed

Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic Rhinitis

Allergic Rhinitis

Australia
Inimmune Corporation
Avance Clinical Pty Ltd.

Recruiting

Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.

Allergic Rhinitis | Allergic Rhinitis Due to Weed Pollen

Australia
GlaxoSmithKline

Completed

A Relative Bioavailability Study of Fluticasone Furoate and Levocabastine

Rhinitis, Allergic, Perennial and Seasonal

Australia
Novartis

Completed

Effects of Multiple Nasal Exposures to House Dust Mite Allergen on Nasal and Body Inflammation and Airway Sensitivity

Allergic Rhinitis

Australia
Sunovion

Completed

Clinical Trial to Assess the Efficacy and Safety of Ciclesonide Hydrofluoroalkane (HFA) Nasal Aerosol for the Treatment of Seasonal Allergic Rhinitis (SAR) to Mountain Cedar in Subjects 12 Years and Older

Seasonal Allergic Rhinitis

United States
Bayside Health

Completed

A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy

Asthma | Allergic Rhinitis

Australia
Idorsia Pharmaceuticals Ltd.

Completed

Study of ACT-129968 in Adult Patients With Seasonal Allergic Rhinitis (SAR)

Seasonal Allergic Rhinitis

United States

3

Subscribe